Walnut Medical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-06-2024
- Paid Up Capital ₹ 1.00 M
as on 15-06-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.75 Cr
as on 15-06-2024
- Revenue -88.95%
(FY 2023)
- Profit -105.11%
(FY 2023)
- Ebitda -96.28%
(FY 2023)
- Net Worth -11.28%
(FY 2023)
- Total Assets -12.33%
(FY 2023)
About Walnut Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.75 Cr.
Amol Bhardwaj and Siddharth Dhawan serve as directors at the Company.
- CIN/LLPIN
U85100HR2016PTC058071
- Company No.
058071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala City, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Walnut Medical Private Limited offer?
Walnut Medical Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Concentrator, Thermometers & Flowmeters, Industrial and Medical Infrared Thermometer, Electrical & Electronic Test Devices, Thermal Scanner & Camera, Physiotherapy & Rehab Aids, Electrotherapy Equipment, Flow Thermometer, Industrial And Medical Infrared Thermometer.
Who are the key members and board of directors at Walnut Medical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Dhawan  | Director | 02-Feb-2016 | Current |
| Amol Bhardwaj | Director | 02-Feb-2016 | Current |
Financial Performance of Walnut Medical.
Walnut Medical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 88.95% decrease. The company also saw a substantial fall in profitability, with a 105.11% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walnut Medical?
In 2023, Walnut Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Jun 2021 | ₹2.50 Cr | Open |
Sidbi Creation Date: 29 Jun 2020 | ₹2.50 M | Open |
How Many Employees Work at Walnut Medical?
Walnut Medical has a workforce of 28 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walnut Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walnut Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
